Study on diagnosis and treatment of diarrhea syndrome with traditional Chinese medicine and traditional Chinese and Western Medicine

注册号:

Registration number:

ITMCTR2100005167

最近更新日期:

Date of Last Refreshed on:

2021-08-10

注册时间:

Date of Registration:

2021-08-10

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

腹泻症候群中医和中西医结合诊疗方案研究

Public title:

Study on diagnosis and treatment of diarrhea syndrome with traditional Chinese medicine and traditional Chinese and Western Medicine

注册题目简写:

English Acronym:

研究课题的正式科学名称:

腹泻症候群中医和中西医结合诊疗方案研究

Scientific title:

Study on diagnosis and treatment of diarrhea syndrome with traditional Chinese medicine and traditional Chinese and Western Medicine

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100049910 ; ChiMCTR2100005167

申请注册联系人:

叶青艳

研究负责人:

周华

Applicant:

Ye Qingyan

Study leader:

Zhou Hua

申请注册联系人电话:

Applicant telephone:

+86 15921188681

研究负责人电话:

Study leader's telephone:

+86 21 20251650

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yeqingyan11@163.com

研究负责人电子邮件:

Study leader's E-mail:

Zhouhuam@hotma.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市黄浦区普安路185号

研究负责人通讯地址:

上海市黄浦区普安路185号

Applicant address:

185 Pu'an Road, Huangpu District, Shanghai, China

Study leader's address:

185 Pu'an Road, Huangpu District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属曙光医院

Applicant's institution:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2018-586-15-01

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属曙光医院伦理委员会

Name of the ethic committee:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine ethics committee

伦理委员会批准日期:

Date of approved by ethic committee:

2018/5/11 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属曙光医院

Primary sponsor:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine

研究实施负责(组长)单位地址:

上海市黄浦区普安路185号

Primary sponsor's address:

185 Pu'an Road, Huangpu District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属曙光医院

具体地址:

上海市黄浦区普安路185号

Institution
hospital:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine

Address:

185 Pu'an Road, Huangpu District, Shanghai, China

经费或物资来源:

国家科技部

Source(s) of funding:

The Ministry of Science and Technology, China

研究疾病:

成人及儿童感染性腹泻

研究疾病代码:

Target disease:

Adult and Children infectious diarrhea

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

完善已建立的新发突发腹泻症候群中西医结合临床救治平台,平时演练,战时应急,确保中医药在第一时间介入新发突发腹泻症候群防治工作。 优化腹泻症候群的中医、中西医结合诊疗方案及应急预案,诊疗方案开展规范的RCT研究,为完善有效方药提供循证证据。

Objectives of Study:

Improve the established clinical treatment platform of diarrhea syndrome, exercise in usual, emergency when outbreak occurs, to ensure that Chinese medicine in the first time to intervene in the prevention and treatment of diarrhea syndrome. Optimize the diarrhea syndrome of traditional Chinese medicineintegrated Chinese and Western medicine diagnosis and treatment programs and emergency preparedness. Carry out standardized RCT research, to improve effective prescriptions and drugs to provide evidence-based evidence.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

成人湿热疫毒证腹泻患者: (1)符合西医诊断标准; (2)符合中医诊断标准; (3)年龄在18-65岁; (4)签署知情同意。 儿童轮状病毒腹泻患者: (1) 符合西医腹泻病诊断标准及中医泄泻诊断标准; (2) 年龄6月-12岁; (3) 发病72h内; (4) 取得家长知情同意, 患儿配合治疗,签属知情同意书。

Inclusion criteria

Diarrhea in adults with damp heat syndrome: (1) Patients who meet the Western medicine diagnosis; (2) Patients who meet the Traditional Chinese medicine diagnosis; (3) Aged 18 to 65 years; (4) Signed informed consent forms. Rotavirus Diarrhea in children: (1) Patients who meet the Western medicine diagnosis and Traditional Chinese medicine diagnosis; (2) Aged 0.5 to 12 years; (3) 72h in the onset of disease (4) Parents informed consent, children with treatment Signed informed consent forms.

排除标准:

成人湿热疫毒证腹泻患者: (1)明确诊断为其他非肠道传染病的发热性疾病; (2)甲类、乙类肠道传染病中的霍乱、伤寒和副伤寒、细菌性和阿米巴性痢疾; (3)合并有心肝肺肾内分泌代谢系统、神经系统、造血系统严重疾病者 (4)既往有明确的溃疡性结肠炎、克罗恩病、肠易激综合征等病史; (5)孕妇或哺乳期妇女; (6)病人不能合作或精神病患者; (7)治疗前使用过抗生素或其他相关药物者。 儿童轮状病毒腹泻患者: (1)实验室检查确诊是霍乱、伤寒、副伤寒、痢疾者; (2)脐部周围皮肤不适合贴敷者; (3)重度脱水者; (4)合并有心、肝、肺、肾、内分泌代谢系统、神经系统、造血系统严重疾病者; (5)正在接受免疫疗法及口服激素治疗者。

Exclusion criteria:

Diarrhea in adults with damp heat syndrome: (1) Definite diagnosis of febrile diseases other than intestinal infectious diseases; (2) Intestinal infectious disease cholera, typhoid, dysentery; (3) With severe primary cardiac, liver, lung, kidney, Endocrine and metabolic system nervous system and hemopoietic system diseases; (4) With ulcerative colitis, Crohn's disease, irritable bowel syndrome and the like in the history; (5) Pregnant or lactating women; (6) The patient cannot cooperate or psychiatric patients; (7) Before the treatment antibiotics or other drugs were used before. Rotavirus Diarrhea in children: 1. Definite diagnosis of cholera, typhoid, dysentery; 2. Severe dehydration patients; 3. The skin around the umbilicus is not suitable for application; 4. With severe primary cardiac, liver, lung, kidney, Endocrine and metabolic system nervous system and hemopoietic system diseases; 5. Receive immunotherapy and oral hormone therapy now.

研究实施时间:

Study execute time:

From 2017-01-01

To      2020-12-31

征募观察对象时间:

Recruiting time:

From 2018-03-01

To      2020-12-01

干预措施:

Interventions:

组别:

儿童轮状病毒腹泻对照组

样本量:

80

Group:

Control group of rotavirus diarrhea of children

Sample size:

干预措施:

安慰剂脐疗+基础治疗

干预措施代码:

Intervention:

umbilical therapy placebo with western

Intervention code:

组别:

成人湿热疫毒证腹泻对照组

样本量:

95

Group:

Control group of damp-heat pestilence syndrome of adult diarrhea

Sample size:

干预措施:

中药安慰剂+基础治疗

干预措施代码:

Intervention:

Traditional Chinese medicine placebo with western

Intervention code:

组别:

儿童轮状病毒腹泻治疗组

样本量:

80

Group:

treatment group of rotavirus diarrhea of children

Sample size:

干预措施:

中药脐疗+基础治疗

干预措施代码:

Intervention:

umbilical therapy with western basis treatment

Intervention code:

组别:

成人湿热疫毒证腹泻治疗组

样本量:

95

Group:

Treatment group of damp-heat pestilence syndrome of adult diarrhea

Sample size:

干预措施:

中药治疗+基础治疗

干预措施代码:

Intervention:

Chinese medicine with western basis treatment

Intervention code:

样本总量 Total sample size : 350

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属曙光医院

单位级别:

三级甲等

Institution/hospital:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

粪便培养

指标类型:

主要指标

Outcome:

stool culture

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

轮状病毒检测

指标类型:

主要指标

Outcome:

Rotavirus detection

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血常规及急性C反应蛋白

指标类型:

主要指标

Outcome:

Routine blood test and C reactive protein

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

电解质

指标类型:

主要指标

Outcome:

Serum electrolyte

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

Faeces

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 0.5
Min age years
最大 65
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

random number table

盲法:

Not stated

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

上海中医药大学附属曙光医院

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

上海中医药大学附属曙光医院

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine

数据管理委员会:

Data Managemen Committee:

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above